Moelisの空売り状況は、投資家がMoelisの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Moelis (NYSE:MC) 株価情報, 空売り情報

Moelis

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

Moelis & Co

Merit Circle - United States Dollar

Mountain & Co I Acquisition Corp Ordinary Shares - Class A

Mountain & Co I Acquisition Corp

Mountain & Co I Acquisition Corp Units (1 Ord Class A & 1/2 War)

Mountain & Co I Acquisition Corp Warrants - (04/11/2026)

MONTEREY CAP ACQUISITION CORP CL A

MONTEREY CAP ACQUISITION CORP RT

MONTEREY CAP ACQUISITION CORP UNIT 1 CL A & 1 RT & 1 WT

MONTEREY CAP ACQUISITION CORP WT EXP

Mountain Crest Acquisition Corp IV

MOUNTAIN CREST ACQUISITION CORP IV RT

Mountain Crest Acquisition Corp IV Units (1 Ordinary Shares& 1 Rights)

MOUNTAIN CREST ACQ V by Mountain Crest Acquisition Corp. V

Mountain Crest Acquisition Corp V

MOUNTAIN CREST ACQUISITION CORP V RT

Mountain Crest Acquisition Corp V Units (1 Ordinary Shares, 1 Rights)

MCAP Inc

Mercari Inc

Mcashchain

MACRO ASIA CORP by Macro Asia Corp

Metropolitan Bank Holding Corp. Common Stock

Metropolitan Bank Holding Corp

MCDEX Token

Macatawa Bank Corp. Com

MOUNTAIN COMM BANCORP INC by Mountain Commerce Bancorp Inc.

Mountain Commerce Bancorp Inc

MADISON COUNTY FINCL INC by Madison County Financial, Inc.

Madison County Financial Inc

MERHAV-CERMC & BLDG MTRLS by MERHAV-CERAMIC & BUILDING MATERIALS CENTER LTD.

Hamat Group Ltd

MICHIGAN COMMUTY BNCRP by Michigan Community Bancorp Ltd.

McBride PLC

MetroCity Bankshares, Inc. - Common Stock

MetroCity Bankshares Inc

MCCHIP RESOURCES INC by McChip Resources, Inc.

McChip Resources Inc

Mestek Inc

MCCOY GLOBAL INC ORD by McCoy Global, Inc.

McCoy Global Inc

MCX Technologies Corp

McDonald's Corp

KMA Holding Inc

McDermott International Ltd Warrants - Class B (30/06/2027)

McDermott International Ltd

MCDERMOTT INT LTD by McDermott International LTD.

MACDONALD MINES EXPL LTD by MacDonald Mines Exploration Ltd.

MacDonald Mines Exploration Ltd

JPMorgan Fundamental Data Science Mid Core ETF

McDermott International Ltd Warrants - Class A (30/06/2027)

MILLENNIUM CELL INC by Millennium Cell, Inc.

Millennium Cell Inc

MONARCH CEMENT CO by Monarch Cement Co. (The)

Monarch Cement Co

MULTICELL TECHS INC by MultiCell Technologies, Inc.

MultiCell Technologies Inc

MCF Energy Ltd

MasterCraft Boat Holdings, Inc. - Common Stock

MasterCraft Boat Holdings Inc

Matthews International Funds Matthews China Active ETF

MATCHAAH HOLDING INC by Matchaah Holdings, Inc.

Matchaah Holdings Inc

MECHANICS BK RICHMOND CAL by Mechanics Bank of Richmond (CA)

Mechanics Bank

MACMAHON HOLDINGS LTD ORD by MacMahon Holdings Ltd.

Macmahon Holdings Ltd

iShares MSCI China ETF

MARUICHI STEEL TUBE LTD by Maruichi Steel Tube Ltd.

Maruichi Steel Tube Ltd

McHenry Bancorp Inc Com (New)

MULTICHOICE GROUP SP/ADR by MultiChoice Group Limited

MultiChoice Group Ltd

Microchip Technology Incorporated - Common Stock

Microchip Technology Inc

Matthews China Discovery Active ETF

M CASH INTEGRASI TBK ORD by M Cash Integrasi Tbk PT

MAUCH CHUNK TR FINCL CORP by Mauch Chunk Trust Financial Corp.

Mauch Chunk Trust Financial Corp

MGM CHINA HOLDINGS ORD by MGM China Holdings, Ltd.

MGM China Holdings Ltd

MGM CHINA HLDGS UNSP/ADR by MGM China Holdings, Ltd.

Marchex Inc

Barings Corporate Investors

MERCIA ASSET MGMT PLC by Mercia Asset Mgmt Plc

Mercia Asset Management PLC

MULTICORP INTL INC by Multicorp International, Inc.

MultiCorp International Inc

MACAU CAP INVSTS INC NEW by Macau Capital Investments, Inc.

Macau Capital Investments Inc

MCI Onehealth Technologies Inc Ordinary Shares - Class A (Sub Voting)

MCJ Co Ltd

McKesson Corp

MALLINCKRODT PB LTD CO by Mallinckrodt plc.

Mallinckrodt PLC

Jade Leader Corp

MORSES CLUB PLC by MORSES CLUB PLC

MCLOUD TECHNOLOGIES INC by MCLOUD TECHNOLOGIES CORP.

mCloud Technologies Corp

Medicale Corp

MCLOUD TECHS CORP 9 PFD A by MCLOUD TECHNOLOGIES CORP.

mCloud Technologies Corp Warrants (29/11/2026)

XAI Madison Equity Premium Income Fund Common Shares

XAI Madison Equity Premium Income Fund

Macnica Holdings Inc

MUCINNO HOLDING INC by Mucinno Holding, Inc.

Mucinno Holding Inc

MILLENNIUM & CPTHRNE HTLS by Millennium & Copthorne Hotels New Zealand Ltd.

Millennium & Copthorne Hotels New Zealand Ltd

Moodys Corp

MCO - United States Dollar

Moss Carbon Credit - United States Dollar

MARIJUANA CO OF AMER INC by Marijuana Company of America, Inc.

Marijuana Company of America Inc

MULTICHOICE GROUP LIMITED by MultiChoice Group Limited

MICROMOBILITY.COM INC A by Micromobility.com Inc.

Micromobility com Inc

Micromobility com Inc Warrants (28/10/2024)

MT CARMEL PUBLIC UTIL CO by Mt. Carmel Public Utility Co.

Mount Carmel Public Utility Co

Midland Capital Holdings Corp Com

MOCHIDA PHARM CO LTD by Mochida Pharmaceutical Co., Ltd.

Mochida Pharmaceutical Co Ltd

MACQUARIE GRP LTD by Macquarie Group, Ltd.

Macquarie Group Ltd

MFS Charter Income Trust

MCRAE INDUS INC A by McRae Industries, Inc.

McRae Industries Inc

MCRAE INDUS INC B by McRae Industries, Inc.

Seres Therapeutics Inc

MICROPORT CRDFLW MD U/ADR by MICROPORT CARDIOFLOW MEDTECH CORP.

MicroPort CardioFlow Medtech Corp

METALS CREEK RES by Metals Creek Resources Corp.

Metals Creek Resources Corp

Monarch Casino & Resort, Inc. - Common Stock

Monarch Casino & Resort Inc

MICRO-MECHANICS LTD ORD by Micro-Mechanics Ltd.

Micro-Mechanics (Holdings) Ltd

MICROPORT SCIENTIFIC CORP by Microport Scientific Corp.

MicroPort Scientific Corp

Microart Inc

MORGAN ADVANCED MTRLS ORD by Morgan Advanced Materials PLC

Morgan Advanced Materials PLC

Micro-X Ltd

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Keefe, Bruyette &amp; Woods analyst Michael Brown upgraded the rating for Ares Management Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARES#NYSE">ARES</a>) from Market Perform to Outperform and raised the price target from $166 to $202. Ares Management shares closed at $171.08 on Thursday. See how other analysts view this stock.</li>
<li>Raymond James analyst Steve Moss upgraded Camden National Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAC#NASDAQ">CAC</a>) from Market Perform to Outperform and announced a $50 price target. Camden National shares closed at $42.29 on Thursday. <a href="https://www.benzinga.com/quote/CAC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keefe, Bruyette &amp; Woods analyst Aidan Hall upgraded the rating for Evercore Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVR#NYSE">EVR</a>) from Market Perform to Outperform and boosted the price target from $269 to $339. Evercore shares closed at $270.57 on Thursday. <a href="https://www.benzinga.com/quote/EVR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keefe, Bruyette &amp; Woods analyst Aidan Hall upgraded Moelis &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) from Market Perform to Outperform and raised the price target from $71 to $86. Moelis shares closed at $71.72 on Thursday. See how other analysts view this stock.</li>
<li>Mizuho analyst Gabriel Moreen upgraded the rating for Spire Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SR#NYSE">SR</a>) from Neutral to Outperform and raised the price target from $65 to $76. Spire shares closed at $65.55 on Thursday. <a href="https://www.benzinga.com/quote/SR/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying EVR stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="606" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/20094406/image-182-1024x606.png" alt="" class="wp-image-701936" style="width:627px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/20094406/image-182-1024x606.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/20094406/image-182-300x177.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/20094406/image-182-768x454.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/20094406/image-182.png 1111w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42616196/jim-cramer-likes-walmart-recommends-buying-this-very-very-good-financial-stock">Jim Cramer Likes Walmart, Recommends Buying This &#8216;Very, Very Good&#8217; Financial Stock</a></li>
</ul>

News

Upgrades

Markets

Analyst Ratings

Trading Ideas

ARES

This Evercore Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

Keefe, Bruyette &amp; Woods analyst Aidan Hall upgrades Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) from Market Perform to Outperform and raises the price target from $71 to $86.

Price Target

Keefe, Bruyette & Woods Upgrades Moelis to Outperform, Raises Price Target to $86

Wells Fargo analyst Michael Brown maintains Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) with a Equal-Weight and raises the price target from $70 to $78.

Wells Fargo Maintains Equal-Weight on Moelis, Raises Price Target to $78

Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Moelis and provided 12-month price targets. The average target is $71.0, accompanied by a high estimate of $92.00 and a low estimate of $60.00. Witnessing a positive shift, the current average has risen by 14.52% from the previous average price target of $62.00.
<img src="https://www.benzinga.com/files/images/story/2024/1733752848_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Moelis. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$92.00</td>
<td>$66.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$66.00</td>
<td>$67.00</td>
</tr>
<tr>
<td>Brennan Hawken</td>
<td>UBS</td>
<td>Raises</td>
<td>Sell</td>
<td>$60.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$67.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$70.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Moelis. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Moelis compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Moelis's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Moelis's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Moelis analyst ratings.</a>
<h2>All You Need to Know About Moelis</h2>
Moelis &amp; Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.
<h3>Financial Insights: Moelis</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Positive Revenue Trend: Examining Moelis's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 0.58% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Moelis's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 6.17%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Moelis's ROE stands out, surpassing industry averages. With an impressive ROE of 4.66%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Moelis's ROA stands out, surpassing industry averages. With an impressive ROA of 1.53%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Moelis's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.58.
<h2>Analyst Ratings: What Are They?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Moelis's Future

Morgan Stanley analyst Ryan Kenny upgrades Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) from Underweight to Overweight and raises the price target from $66 to $92.

Morgan Stanley Upgrades Moelis to Overweight, Raises Price Target to $92

Revealing a significant insider sell on November 12, Christopher Callesano, Principal Accounting Officer at Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>), as per the latest SEC filing.
What Happened: According to a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001596967/000095017024125709//Archives/edgar/data/1596967/000095017024125709/0000950170-24-125709-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday, Callesano sold 885 shares of Moelis. The total transaction value is $70,800.
The latest market snapshot at Wednesday morning reveals Moelis shares down by 0.0%, trading at $76.93.
<h3>Delving into Moelis's Background</h3>
Moelis &amp; Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.
<h3>Key Indicators: Moelis's Financial Health</h3>
Revenue Growth: Moelis's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 0.58%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Analyzing Profitability Metrics:
<ul>
<li>
Gross Margin: With a low gross margin of 23.05%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Moelis's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.23.
</li>
</ul>
Debt Management: Moelis's debt-to-equity ratio is below the industry average. With a ratio of 0.58, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Analyzing Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current Price to Earnings ratio of 145.15 is higher than the industry average, indicating the stock is priced at a premium level according to the market sentiment.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 5.9 is above industry norms, reflecting an elevated valuation for Moelis's stock and potential overvaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an impressive EV/EBITDA ratio of 130.9, Moelis demonstrates exemplary market valuation, surpassing industry averages.
</li>
</ul>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Uncovering the Importance of Insider Activity</h3>
Insider transactions are not the sole determinant of investment choices, but they are a factor worth considering.
Considering the legal perspective, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, according to Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Nevertheless, insider sells may not necessarily indicate a bearish view and can be influenced by various factors.
<h3>Deciphering Transaction Codes in Insider Filings</h3>
Examining transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often concentrate on those unfolding in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001596967">Check Out The Full List Of Moelis's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;utm_source=benzinga-insights">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Principal Accounting Officer Of Moelis Sold $70K In Stock

Financial stocks are basking in a post-election rally after Donald Trump's election win as investors anticipate a friendlier regulatory landscape for banks, brokers and<a href="https://www.benzinga.com/markets"> consumer finance companies</a>.
With expectations of deregulation and possible tax cuts, traders are piling into financials at levels not seen in years.
The Financials Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>) jumped over 5% last week, hitting fresh record highs, while weekly inflows surged to $1.573 billion—the highest in over two years. 
Regional banks, in particular, were on fire, with the SPDR S&amp;P Regional Banking ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRE#NYSE">KRE</a>) skyrocketing nearly 11% and seeing $1.09 billion in inflows, marking its largest influx of money since March 2023.
<h3 class="wp-block-heading">Key Drivers: Deregulation, Tax Cuts Fuel Investor Optimism</h3>
Investors are betting on a wave of Trump-favored financial reforms that could benefit the sector. 
Richard Ramsden, a Goldman Sachs analyst, highlighted that "the market is pricing in the potential for changes to a number of proposed regulations, a step up in capital markets activity, as well as the potential for a reduction in the corporate tax rate."
Potential regulatory changes under Trump could include:
<ol>
<li>401K Reform: Opening up retirement plans to private investments could attract a flood of new capital.</li>
<li>Relaxed Antitrust Regulations: A more lenient antitrust stance may spark increased mergers and acquisitions (M&amp;A) activity.</li>
<li>Reduced SEC Oversight: There is limited clarity on whether the SEC will continue probing brokers' sweep pricing practices.</li>
<li>Crypto-Friendly Policies: Financial firms with crypto exposure may benefit from a more favorable regulatory environment and higher digital asset prices.</li>
</ol>
<h3 class="wp-block-heading">Goldman Sachs's Top Picks Among Financials Stocks</h3>
In anticipation of these shifts, Ramsden and his team have identified several top picks across the financial sector. 
Here's where they see the biggest potential gains:
<ul>
<li>Large Banks: Citigroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>), JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), and Wells Fargo &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>).</li>
<li>Consumer Finance: Bread Financial Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFH#NYSE">BFH</a>), Synchrony Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYF#NYSE">SYF</a>), and Capital One Financial Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>).</li>
<li>Capital Markets: Blackstone Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>), Apollo Global Management Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>), KKR &amp; Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>), LPL Financial Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPLA#NASDAQ">LPLA</a>), Tradeweb Markets Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TW#NASDAQ">TW</a>), Evercore Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVR#NYSE">EVR</a>), and PJT Partners Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PJT#NYSE">PJT</a>).</li>
</ul>
<h3 class="wp-block-heading">Steeper Yield Curve Expected to Boost Regional Banks</h3>
As markets react to potential economic stimulus and reduced regulatory pressure, analysts anticipate a steeper yield curve, which could be a windfall for banks with heavy exposure to fixed-rate assets. 
Around 60% of both regional and large banks' balance sheets consist of fixed-rate holdings, positioning them to profit as long-term rates rise.
Ramsden's picks for banks that stand to gain the most from a steeper yield curve include:
Regional Banks: 
<ul>
<li>Citizens Financial Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CFG#NYSE">CFG</a>)</li>
<li>Comerica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>)</li>
<li>First Hawaiian Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FHB#NASDAQ">FHB</a>)</li>
<li>Zions Bancorporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>)</li>
<li>Truist Financial Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>)</li>
<li>Huntington Bancshares Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBAN#NASDAQ">HBAN</a>)</li>
<li>Regions Financial Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>)</li>
<li>PNC Financial Services Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNC#NYSE">PNC</a>)</li>
<li>Ally Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>).</li>
</ul>
<h3 class="wp-block-heading">Surge in Capital Velocity: M&amp;A and Trading Boost Expected</h3>
Trump's pro-business stance is also expected to accelerate capital velocity in the M&amp;A and equity capital markets, providing a strong backdrop for trading activity. 
According to Ramsden, large banks like Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) could be the biggest beneficiaries, while among regional banks,&nbsp;KeyCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEY#NYSE">KEY</a>)&nbsp;and&nbsp;Citizens Financial Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CFG#NYSE">CFG</a>)&nbsp;stand out.
Investment banks could also see a boost, with&nbsp;Jefferies Financial Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JEF#NYSE">JEF</a>),&nbsp;Moelis &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>),&nbsp;PJT Partners Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PJT#NYSE">PJT</a>), and&nbsp;Piper Sandler Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PIPR#NYSE">PIPR</a>)&nbsp;positioned to capitalize on a more active M&amp;A market. 
In the alternative asset management space,&nbsp;Carlyle Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CG#NASDAQ">CG</a>),&nbsp;KKR,&nbsp;Apollo,&nbsp;TPG Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>), and&nbsp;Ares Management Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARES#NYSE">ARES</a>)&nbsp;are expected to benefit from an uptick in private equity deal flow.
<h3 class="wp-block-heading">Tax Cut Hopes Could Supercharge Regional Banks</h3>
Financial stocks are uniquely positioned to benefit from any corporate tax reductions, given that 90% of their earnings come from the U.S. and are currently taxed at an average rate of 23%. After the 2017 tax reform slashed the corporate tax rate from 35% to 21%, financials saw their effective tax rate drop by 10 percentage points.
Ramsden estimates that if the Trump administration pursues another tax cut, regional banks would likely see the most significant upside. 
His top tax-cut beneficiaries include&nbsp;Moelis &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>),&nbsp;American Express Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>),&nbsp;Evercore Inc.,&nbsp;Bread Financial Holdings,&nbsp;Piper Sandler,&nbsp;First Citizens BancShares Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCNCA#NASDAQ">FCNCA</a>),&nbsp;Synovus Financial Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNV#NYSE">SNV</a>), and&nbsp;Western Alliance Bancorporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>).
<h3 class="wp-block-heading">Insurers to Benefit from Steeper Curve, P&amp;C Pricing Power</h3>
The insurance sector may also stand to gain under Trump's pro-business policies. Ramsden expects potential increases in claim costs but sees positive momentum for property and casualty pricing.
Insurers with substantial U.S. exposure and a favorable position on the yield curve could see tailwinds.
Ramsden's picks in the insurance space include&nbsp;W.R. Berkley Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>),&nbsp;Hartford Financial Services Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIG#NYSE">HIG</a>), and&nbsp;The Travelers Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>), which he believes are better positioned than brokers to benefit from these trends.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/24/11/41857487/exclusive-trump-victory-triggers-reshoring-rally-as-supply-chain-security-outweighs-cost">EXCLUSIVE: Trump Victory Triggers &#8216;Reshoring&#8217; Rally As Supply Chain Security Outweighs Cost</a></li>
</ul>
Image created using artificial intelligence via Midjourney and Shutterstock.

Analyst Color

Equities

Large Cap

Mid Cap

Sector ETFs

Politics

Small Cap

Econ #s

Economics

ETFs

ALLY

FCNCA

HBAN

LPLA

PIPR

ZION

Trump Trade Sparks Biggest Financial Stock Inflows In 2 Years

In the latest quarter, 4 analysts provided ratings for Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>), showcasing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Moelis, presenting an average target of $65.75, a high estimate of $70.00, and a low estimate of $60.00. This upward trend is evident, with the current average reflecting a 8.37% increase from the previous average price target of $60.67.
<img src="https://www.benzinga.com/files/images/story/2024/1729792840_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A comprehensive examination of how financial experts perceive Moelis is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$66.00</td>
<td>$67.00</td>
</tr>
<tr>
<td>Brennan Hawken</td>
<td>UBS</td>
<td>Raises</td>
<td>Sell</td>
<td>$60.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$67.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$70.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Moelis. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Moelis compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Moelis's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Moelis's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Moelis analyst ratings.</a>
<h2>All You Need to Know About Moelis</h2>
Moelis &amp; Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.
<h3>Moelis's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Moelis displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 47.1%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Financials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Moelis's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 4.97%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Moelis's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 3.65%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Moelis's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.28%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.59.
<h2>Analyst Ratings: Simplified</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Moelis Stock

Morgan Stanley analyst Ryan Kenny maintains Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) with a Underweight and lowers the price target from $67 to $66.

Morgan Stanley Maintains Underweight on Moelis, Lowers Price Target to $66

Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.21 by 4.76 percent. The company reported quarterly sales of $280.730 million which beat the analyst consensus estimate of $273.187 million by 2.76 percent. This is a 1.10 percent increase over sales of $277.665 million the same period last year.

Earnings

Earnings Beats

Moelis Q3 2024 Adj. EPS $0.22 Beats $0.21 Estimate, Sales $280.730M Beat $273.187M Estimate

Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) is set to give its latest quarterly earnings report on Wednesday, 2024-10-23. Here's what investors need to know before the announcement.
Analysts estimate that Moelis will report an earnings per share (EPS) of $0.24. 
Moelis bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Overview of Past Earnings</h3>
The company's EPS beat by $0.08 in the last quarter, leading to a 6.42% increase in the share price on the following day.
Here's a look at Moelis's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.10</td>
<td>0.13</td>
<td>-0.11</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.18</td>
<td>0.22</td>
<td>-0.06</td>
<td>-0.15</td>
</tr>
<tr>
<td>Price Change %</td>
<td>6.0%</td>
<td>-7.000000000000001%</td>
<td>1.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729620196_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Moelis were trading at $70.64 as of October 21. Over the last 52-week period, shares are up 78.93%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/MC/earnings">To track all earnings releases for Moelis visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

An Overview of Moelis's Earnings

Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) in the last three months.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $59.86, a high estimate of $70.00, and a low estimate of $50.00. This upward trend is evident, with the current average reflecting a 10.85% increase from the previous average price target of $54.00.
<img src="https://www.benzinga.com/files/images/story/2024/1728406813_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of Moelis among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brennan Hawken</td>
<td>UBS</td>
<td>Raises</td>
<td>Sell</td>
<td>$60.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$67.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$70.00</td>
<td>-</td>
</tr>
<tr>
<td>Kenneth Worthington</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$51.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Aidan Hall</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$60.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$61.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Kenneth Worthington</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$50.00</td>
<td>$54.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Moelis. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Moelis compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Moelis's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Moelis's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/MC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Moelis analyst ratings.</a>
<h2>About Moelis</h2>
Moelis &amp; Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.
<h3>Financial Insights: Moelis</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Positive Revenue Trend: Examining Moelis's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 47.1% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Moelis's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 4.97%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Moelis's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 3.65%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Moelis's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.28%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.59, Moelis adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Analyst Ratings: Simplified</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

In-Depth Examination Of 7 Analyst Recommendations For Moelis

UBS analyst Brennan Hawken maintains Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) with a Sell and raises the price target from $54 to $60.

UBS Maintains Sell on Moelis, Raises Price Target to $60

Morgan Stanley analyst Ryan Kenny maintains Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) with a Underweight and raises the price target from $61 to $67.

Comments

Moelis

空売り

Moelis (NYSE:MC) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル